Over the last decades, increasing interest has been attracted towards the nanotechnology which provide a set of promising research tools and theranostic approaches. Tremendous research efforts in nanofabrication technology have led to the production or drugs against the metabolism or excretion. Furthermore, controlled delivery and targeted therapy may result in the improved materials capable of interaction with the nervous systems, and nanopharmaceuticals with minimal toxicity and improved biohas been highlighted. Biomed Rev 2018; 29: 17-26
INTRODUCTION
Enormous research efforts in nanotechnology and application tions have provided attractive research tools and theranostic approaches against a variety of disorders. High-resolution imaging may provide deeper understanding about the pathomechanisms of disorders leading to the selection of more appropriate treatment strategies and obtaining better treatment outcomes. Real time detection of a variety of biomarkers and molecular signals or using the nanoscale-targeted magnetic resonance imaging (MRI) contrast agents demonstrate the immense potential of nanomaterials in the early diagnostics and prognostics (1, 2) . Development of the biocompatible nanomaterials for protection of therapeutics against the metabolism or excretion and overcoming the chemo-resistance Hassanzadeh, Atyabi and Dinarvand might result in the improved treatment outcome. In this context, designing the nanopharmaceuticals with improved halflives and bioavailability and targeted drug delivery systems using a variety of nanoparticles including the polymer-or lipid-based ones has attracted a growing interest. The ability of nanocarriers for improving the pharmacokinetics and in vivo stability of oligonucleotides, peptides, and proteins has conventional treatment strategies against the neurological diseases has resulted in designing the new treatment options such as the development of nanodevices capable of interaction with the nervous systems or multifunctional nanoparticles for delivery of therapeutics across the blood-brain barrier (BBB) for improving their bioavailability and reducing adverse effects (8) . Nanotechnology along with tissue engineering are promising approaches for designing the controlled release systems containing the bioactive proteins or a variety of drugs which may re-establish the functional neuronal networks or neuronal connectivity (9) (10) (11) . Carbon nanotubes (CNTs) with superior mechanical properties, improved biocompatibility, and high thermo-electrical conductivities, have shown enormous for biosensing, non-invasive and high-resolution imaging, CNTs may be applied as the carriers of therapeutics against a variety of disorders (12-18). Early detection of neoplastic or precancerous lesions has remained challenging that may be imaging technologies for early detection. Development of nanotech-based imaging technologies enables to provide betmolecular expressions of neoplasms, and detect the early-stage tumors (19). In recent years, increasing research efforts have been attracted towards the development of novel nanobiosensors and nanotherapeutics for cancer theranostics (20-22). Nanocantilever arrays and nanowires may be applied for early detection of malignant lesions that may be of paramount importance in cancer therapy (23). Using nanocantilever, nanowire, and nanotube arrays facilitates the transition from single to multiple biomarker detection and selection of more appropriate strategies for cancer therapy (24). Nanoparticles may also be applied for biomarker detection ex vivo. For nanoparticles may be used for recognition of the molecular signatures and ultrasensitive detection of DNA, respectively (26). In prostate cancer, lymph-node metastases may not be detectable by traditional approaches, however, application of the lymphotropic paramagnetic nanoparticles may be helpful in this regard (27) . Bimodal nanoparticles as the carriers of brain tumor imaging and intra-operative visualization of the lesions (28). In mice, gadolinium-loaded polymeric dendrimers have been successfully applied for imaging the lymphatic of breast cancer (29). Nanoparticle probes which are targeted with recognition agents enable to obtain valuable information relating the distribution or abundance of cancer markers (30). Moreover, angiogenesis has been successfully imaged in the animals receiving targeted nanoparticle formulations (31). development of the next generation of therapeutics.
NANOVECTORS
These nanostructures are usually applied for non-invasive visualization of the molecular markers or targeted delivery of therapeutics. Nanovectors protect the active agents against the enzymatic degradation, reduce the clearance time of peptide drugs, and overcome the biological barriers. Multifunctionality and delivery of large amounts of imaging agents advantages of nanovectors. Using the biological targeting moieties enables to achieve a wide variety of new therapeutics. Several polymer-based nanovectors have been represented for application in the clinical settings (32, 33). For systemic administration of the nanovectors, silica and silicon may be applied (34, 35) . Furthermore, metal-based nanovectors may be applied for localized thermal ablation that might be of sigof the active agent-loaded nanovectors may be achieved via conjugation with recognition moieties leading to the enhanced tors over traditional antibody-guided treatment strategies include the capability of carrying various targeting agents, delivery of greater therapeutic payloads, co-localized delivery of multiple active agents, and bypassing the biological barriers (37) . Indeed, barrier-avoiding nanovectors may provide nanovectors provides the optical-imaging signals that might be promising in targeted cancer therapies (38) . Tumor-targeting mechanism or enhanced permeation and retention (EPR) is a Nanoparticles reshape the biomedical industry key issue which should be taken into account in development of the novel formulations of nanovectors (39) . In this sense, application of the appropriate mathematical formulations may be useful for designing the nanovectors with optimized EPR (40) . Co-administration of a bradykinin antagonist has been shown to increase the endothelial vascular permeability that may result in the enhanced EPR targeting of nanovectors (41) . As follows, the widely-applied nanoparticle systems for biomedical applications including the polymeric and lipid nanoparticles have been highlighted.
POLYMERIC NANOPARTICLES
Over the last decade, a variety of polymers have been developed for preparation of nanoparticles as the solid nanovectors which are usually prepared using the single materials. Polymeric nanoparticles with high loading capacity appear to be more stable, easy-to-prepare, and safer than other nanocarriers. Nonimmunogenicity and rapid elimination from the body make the selected polymers as suitable candidates for development of nanoparticles with tunable surface properties and capable of encapsulating a variety of therapeutics. Selecting the proper polymeric carriers facilitates the controlled release of loaded scalability, biodegradability, and biocompatibility, appropriate linker design is of key importance for obtaining the optimal treatment outcome (44) . Polymeric nanoparticles containing atherosclerotic plaques. This type of nanoparticles have been matory agents (45) . Polymers may also be applied for delivery of water-soluble proteins and bio-imaging. Near-infrared dye loaded polymeric nanoparticles have been applied for cancer imaging and treatment (46) . Using polyethyleneimine for preparation of biocompatible and cell-permeable polymeric be useful for visualizing caspase-dependent apoptosis (47) .
noparticles may be applied for delivery of proteins, nucleic acids, or small molecule drugs to the central nervous system (CNS). For drug delivery into the CNS, various synthetic or natural polymers including the polyesters, poly(methylidene malonates), poly(alkylcyanoacrylates), or polysaccharides may be applied for preparation of the nanoparticles that may result in promising therapeutic effects against the neurodegenerative disorders or malignancies (48) (49) (50) . In recurrent gliomas, chemotherapeutic-loaded polymer nanoparticles capable of controlled drug delivery have improved the survival of patients (51) . For treatment of the intracranial tumors, convectionenhanced delivery (CED) of drug-loaded polymer nanoparticles has been suggested as a useful approach which may transport the nanoparticles over the clinically relevant volumes of distribution (52, 53) . Poly(lactic-co-glycolic acid) (PLGA) nanoparticles loaded with camptothecin have been delivered via CED, an effective approach against the intracranial tumor model (54). Because of the attractiveness of CED, this strategy has been applied in the randomized clinical trials for delivery systemic toxicity (55) . Meanwhile, intracranial CED may be impractical for a number of patients due to its invasivity. In this respect, controlling the size, surface coatings, and charge of polymer nanoparticles should be taken into consideration for more effective drug delivery (56) . Microspheres have been towards the brain. Polymeric microspheres fabricated from a wide variety of materials such as chitosan, poly(methylidene malonate), poly(epsilon-caprolactone), or PLGA, may be applied for local delivery of various therapeutic agents against the malignant gliomas (57, 58) . Noteworthy, delivery of the polymeric nanoparticles into the CNS largely depends on the adsorptive-or receptor-mediated transcytosis using targeting ligands or cell-penetrating peptides. Poly(butylcyanoacrylate) based nanocarriers for drug delivery into the CNS (59) . Polysorbate 80, a commonly used surfactant, increases the CNS penetration of PBCA nanoparticles that may be due to the with endothelial receptors of BBB, or reducing the clearance of nanoparticles (60, 61) . Coating of PLGA nanoparticles of drug-loaded nanoparticles across the BBB (62). Following the systemic administration, PLGA-, poly(glycolic acid) (PGA)-, or poly(lactic acid) (PLA)-based nanoparticles may penetrate the BBB in a size-dependent fashion (63) . In order peptide has been attached to the surface of drug-loaded PLA nanoparticles leading to the enhanced transport of nanoparticles into the CNS (64) . Chitosan is a naturally occurring biodegradable and biocompatible polysaccharide which may be of therapeutics across the BBB (65). Following the systemic administration, chitosan nanoparticles capable of delivery of dopamine, caspase inhibitors, or peptides, have provided Hassanzadeh, Atyabi and Dinarvand promising neuroprotective effects (66) . Moreover, cationic polymers may be applied for development of nanoparticles for nanoparticles with rabies virus glycoprotein-derived peptides enables the transvascular delivery of small interfering RNA to the CNS (67).
LIPID NANOPARTICLES
Lipid-based colloidal drug delivery systems including the nanostructured lipid carriers (NLCs) and solid lipid nanoparticles (SLNs) have been designed as the alternatives of polymeric nanoparticles, liposomes, or emulsions. This type of nanoparticles capable of targeted drug delivery and protecting the loaded therapeutics against the enzymatic degradation, (68) . Because of the limitations of SLNs including the drug expulsion during the storage and limited drug loading capacity (69) , NLCs (the mixture of liquid and solid lipids) with longterm stability, suitable biocompatibility, high drug loading the reduced drug dosage and side effects, are usually preferred for encapsulating of poorly water-soluble therapeutics (70) . Because of the biocompatibility of excipients and aqueous nature, NLCs are suitable for intravenous drug delivery (71) .
Application of NLCs in cancer chemotherapy may result in the improved therapeutic index of loaded anti-cancer agents (72) . Besides application for tumor targeting, NLCs as sustained-release drug carrier systems have been represented as promising nanoformulations against the ischemic neural injuries, fungal infections, and leukemia (73) (74) (75) (76) (77) (78) .
Atorvastatin, a widely applied lipid-regulating drug, -
In this respect, designing the drug delivery systems capable of improving drug solubility and bypassing the hepatic metabolism might be of therapeutic importance. Development of atorvastatin-loaded NLCs by high-speed homogenization and the drug indicating the appropriateness of NLC formulations (79) . As compared to the commercially available tacrolimus ointment, tacrolimus-loaded NLCs have shown enhanced skin penetration (80) . Regarding the inhalation drug delivery, NLCs have shown longer residence time in lungs than liposomes, emulsions, or polymeric nanoparticles and greater stability against the shear forces created during the nebulization that may be due to their lipophilic character and small particle size. This make NLCs suitable for loading drugs against the pulmonary disorders (81). Furthermore, providing sustained drug release and prolonged residence time for the entrapped lipophilic drugs represent NLCs as promising nanocarriers for ocular drug delivery (82) . Using NLCs, it may also be possible to increase the stability and bioavailability of drugs against the cardiovascular disorders and prolong their circulation time that may result in the improved treatment outcome (83) .
APPLICATION OF MODELING APPROACHES: THE NECESSITY OF NANOMEDICINE
Despite the innovative techniques in nanotechnology which may be applied for development of stable nanoparticulate systems capable of high loading capacity and targeted delivery of theranostics, data reliability, personalized theranostics, or occurrence of the unexpected phenomena appear as challenging issues (84) . Modeling and simulation techniques may be applied in order to design safer nanoparticles with appropriate bioactivity and selectivity (85) . Multi-scale modeling techassess their functional characteristics in vivo. It may also be possible to evaluate the effects of surface properties, shape, or cellular uptake and predict nanoparticle behavior in the biological systems (86) . Moreover, the cause(s) of failure in targeted drug delivery may be analyzed leading to the eling of the adhesion kinetics, transportation, and cellular sequestration and increase their bioavailability (88) . Furthermore, using the suitable algorithms enables to calculate than the smallest single-walled carbon nanotubes, may be applied for transferring proteins, genes, or ions into the cells. Application of the computational quantum chemistry enables to develop stable structures with highly-symmetrical geometry (90) . For mimicking tumor microenvironment, nanoparticles may be incubated in co-culture systems that may facilitate designing the effective drug delivery systems. cellular uptake of nanoparticles or determining the co-culture ratios in the heterogeneous populations of cells might be of Nanoparticles reshape the biomedical industry models may provide opportunities for personalized treatment resistance, adverse effects, or treatment response as well as pharmacogenomic analysis may be possible using the suitable modeling techniques (93) . For personalized nanoparticle drug delivery into the blood vessels, isogeometric analysis may be applied for simulating the vascular permeability, binding, and transport of nanoparticles. Appropriate modeling approaches enable to assess the hydrodynamic conditions, vascular geometry, or surface density of the endothelial receptors (94) . Besides providing a deeper knowledge about the pathomechanism of CNS diseases, modeling approaches enable tracking the real-time dynamics of receptors, evaluation of the information processing, signaling cascades, dynamics of synaptic connectivity, and performance of nano-engineered devices or multifunctional nanoparticles capable of neuronal stimulation (95, 96 ) . Modeling methods may also be of key importance for designing the nanobiosensors or nanorobots plications (97-100). It appears that modeling approaches along with nanointerventions would dramatically affect the health-care system.
CONCLUSION
Selective drug delivery to the target tissues or organs which results in the improved bioavailability and reduced side effects of therapeutics, has been a challenging issue. Nanotechnology, an attractive interdisciplinary topic by which a wide variety of highly-advanced devices or biomaterials may be developed for early disease diagnosis or targeted therapy, has opened up a novel frontier in biomedicine. Nanotech-based research efforts have provided remarkable of overcoming the biological barriers and providing improved treatment outcomes. Using nanotechnology tools enables to obtain deeper knowledge about the pathomechanisms of a variety of disorders leading to the development of more effective therapeutics. Designing the nanopharmaceuticals with minimal toxicity and improved bioavailability as well as the biomaterials capable of interaction with biological scale modeling, high-performance simulation techniques, next generation therapeutics. 
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